Comparative Pharmacology
Head-to-head clinical analysis: INFUVITE PEDIATRIC versus MULTIFUGE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INFUVITE PEDIATRIC versus MULTIFUGE.
INFUVITE PEDIATRIC vs MULTIFUGE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
INFUVITE PEDIATRIC is a multivitamin preparation that provides essential vitamins (A, B complex, C, D, E, K, and folic acid) that act as cofactors and coenzymes in various metabolic pathways, including energy production, protein and nucleic acid synthesis, and antioxidant defense.
Multifuge is a combination product containing an antihistamine and a decongestant. The antihistamine (chlorpheniramine) competitively antagonizes histamine H1 receptors, reducing allergic symptoms. The decongestant (pseudoephedrine) stimulates alpha-adrenergic receptors, causing vasoconstriction and reducing nasal congestion.
INFUVITE PEDIATRIC is not indicated for adult use; adult multivitamin formulations are recommended.
IV: 10 mg/kg body weight as a single dose; repeated every 48 hours as needed.
None Documented
None Documented
Terminal half-life varies by vitamin: thiamine ~20-30 min; riboflavin ~1.3 h; pyridoxine ~2-3 h; ascorbic acid ~16 d; retinol (vitamin A) ~6-18 h; ergocalciferol (D2) ~2-3 d; alpha-tocopherol (E) ~12 h; phytonadione (K1) ~6-8 h. Clinical context: rapid clearance of water-soluble vitamins necessitates daily dosing; fat-soluble vitamins accumulate with repeated dosing.
The terminal elimination half-life is 7-9 hours in adults with normal renal function. This may be prolonged (up to 20-30 hours) in patients with severe renal impairment (CrCl <30 mL/min), necessitating dose adjustment.
Excretion of vitamins in Infuvite Pediatric is primarily renal for water-soluble vitamins (B-complex and C), with negligible biliary/fecal elimination. Fat-soluble vitamins (A, D, E, K) are not readily excreted; small amounts may appear in bile/faeces. Specific %: not available due to extensive metabolism and tissue storage.
Renal excretion of unchanged drug accounts for 60-70% of the administered dose, with the remainder undergoing hepatic metabolism to inactive metabolites that are excreted renally. Fecal elimination is minimal (<5%).
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement